Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
T Stamp A | IDAI | May 17, 2024 | 0.68 | +0.40 |
T-Mobile US | TMUS | May 17, 2024 | 164.00 | +0.26 |
T. Rowe Price Blue Chip Growth ETF | TCHP | May 17, 2024 | 36.17 | +0.11 |
T. Rowe Price Dividend Growth ETF | TDVG | May 17, 2024 | 38.56 | +0.23 |
T. Rowe Price Equity Income ETF | TEQI | May 17, 2024 | 40.20 | +0.25 |
T. Rowe Price Group | TROW | May 17, 2024 | 116.76 | +0.61 |
T. Rowe Price Growth Stock ETF | TGRW | May 17, 2024 | 34.79 | +0.10 |
T2 Biosystems | TTOO | May 17, 2024 | 5.64 | 0.00 |
Taboola.com | TBLA | May 17, 2024 | 4.32 | -0.46 |
Tactile Systems Technology | TCMD | May 17, 2024 | 13.73 | +0.51 |
Taitron Components A | TAIT | May 17, 2024 | 2.97 | +3.48 |
Taiwan Fund | TWN | May 17, 2024 | 39.99 | +0.69 |
Taiwan Index MSCI Ishares | EWT | May 17, 2024 | 50.98 | +0.30 |
Taiwan Semiconductor Manufacturing ADR | TSM | May 17, 2024 | 151.68 | -0.36 |
Take-Two Interactive Software | TTWO | May 17, 2024 | 147.84 | +1.20 |
Takeda Pharmaceutical ADR | TAK | May 17, 2024 | 13.22 | -0.68 |
TAL Education Group ADR | TAL | May 17, 2024 | 12.93 | -0.84 |
Talis Biomedical | TLIS | May 17, 2024 | 8.98 | -1.97 |
Talkspace | TALK | May 17, 2024 | 2.75 | -1.79 |
Talos Energy | TALO | May 17, 2024 | 12.14 | +1.17 |
Talphera | TLPH | May 17, 2024 | 1.08 | -6.09 |
Tandem Diabetes Care | TNDM | May 17, 2024 | 47.30 | +0.79 |
Tanger | SKT | May 17, 2024 | 27.74 | -0.54 |
Tango Therapeutics | TNGX | May 17, 2024 | 7.52 | -3.47 |
Tantech | TANH | May 17, 2024 | 0.66 | +14.24 |
Taoping | TAOP | May 17, 2024 | 0.80 | +9.91 |
Tapestry | TPR | May 17, 2024 | 42.32 | -0.47 |
Targa Resources | TRGP | May 17, 2024 | 117.67 | +1.33 |
Target | TGT | May 17, 2024 | 160.13 | -0.32 |
Target Global Acquisition I A | TGAA | May 17, 2024 | 11.30 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.